Acumen Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -6.31%
- Market cap
- $15.79M
- 72.33M shares
- Filings
- 365
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+51.5% FY25 yoy
- $15.79M
- —
- —
- 0.5×
- -732.32%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Total Interest and Dividend Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $10,791,000 | reported | |
| FY 2022 | 2022-12-31 | $2,392,000 | reported |
Biological products, except diagnostic substances
Acumen Pharmaceuticals, Inc. is the 147th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
PLURPluri Inc.$1.0M24.0%2,344.6%$17.3MATYRaTYR PHARMA INC$190.0K19.1%39,009.5%$16.3MPASGPassage BIO, Inc.———$16.2M
ABOSAcumen Pharmaceuticals, Inc. (this company)———$15.8M
BCLIBrainstorm Cell Therapeutics Inc.———$15.6MDYAIDyadic International Inc$3.1M11.6%238.3%$13.3MSCLXScilex Holding Co$30.3M46.5%1,236.4%$13.2MINABIN8BIO, Inc.———$12.7MALGSAligos Therapeutics, Inc.$2.2M39.5%1,106.7%$12.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR